Free Trial

Verrica Pharmaceuticals (VRCA) SEC Filings & 10K Form

$8.35
-0.70 (-7.73%)
(As of 05/23/2024 ET)

Recent Verrica Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/15/2024
6:45 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:31 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/13/2024
7:01 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
6:46 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
6:35 AM
Verrica Pharmaceuticals (Filer)
Form DEFA14A
04/19/2024
6:40 AM
Verrica Pharmaceuticals (Filer)
Form ARS
04/19/2024
6:30 AM
Verrica Pharmaceuticals (Filer)
Form DEF 14A
03/19/2024
3:31 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
7:05 AM
Verrica Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
6:45 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:47 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:10 AM
Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
7:01 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:27 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
6:21 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:52 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:49 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:32 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:33 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:34 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:35 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
9:28 AM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144/A
11/15/2023
3:42 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2023
3:54 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
6:54 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
6:41 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
3:37 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
3:38 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
3:39 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
3:39 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
3:40 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
6:40 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:52 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2023
5:47 PM
Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
6:31 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
8:02 AM
PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
8:03 AM
Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
WARNING about the death of the U.S. dollar… (Ad)

Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)

Get Colonial Metals' new Precious Metals Investment Guide.
06/12/2023
8:03 AM
Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
8:05 AM
Ballaron Craig (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VRCA) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners